VYNE Therapeutics Shares Jump On Encouraging Preclinical Data From VYN201 Program In Rheumatoid Arthritis
March 30, 2022 at 11:37 AM EDT
VYNE Therapeutics Inc(NASDAQ: VYNE)announced positive preclinical datafrom its VYN201 program in the rheumatoid ...